MRD / Regn No. : 20240000240 Date : 08/06/2026
Patient Name : Jannatul Mawa Mou Age & Gender : 34 Yrs. / Female
Contact No. : 8489180209 UHID :
Ht / Wt / BMI : 153 / 84 / 35.88 BP S / BP D : 120 / 80
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (19/Mar/2023) | PREMATURE OVARIAN INSUFFICIENCY (19/Mar/2017) | CARICINOMA ENDOMETRIUM (19/Mar/2017) | OBESITY (30/Jun/2017) |
Subjective : HX OF CA ENDOMETRIUM,TYPE 2 DM FOR 1 YEAR,HAS STOPPED RYBELSUS
Objective : NONE
Analysis : TYPE 2 DM,PREMATURE MENOPAUSE,HX OF ENDOMETRIAL CA,OBESITY,DYSLIPIDEMIA
Plan : START GLP1RA,SEE ME IN 1 MONTH VIA TELECONSULT  
Salient Investigations : DEXA MACHINE: HOLOGIC - | HIP BMD: 0.939 g/cm2 | HIP T SCORE: 0.8 | SPINE BMD: 0.947 g/cm | SPINE T SCORE: -1.0
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET DAPAGLIFLOZIN 10 MG
GLUCRETA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS. KEEP GENITAL AREA CLEAN. IF YOU HAVE GENITAL ITCHING OR BURNING DURING MICTURITION INFORM CLINIC
2 INJECTION SEMAGLUTIDE
SEMALIX 0.25 MG
Medicine For DIABETES OBESITY MASLD CAD
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING OR EYE DISTURBANCE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 08/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: